Related Experiment Video
Updated: Aug 20, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
[Buprenorphine or methadone for detoxification of young opioid addicts?]
Roland Ebner1, Wolfgang Schreiber, Christoph Zierer
1Bezirksklinikum Mainkofen, Psychiatrische Klinik. r.ebner@mainkofen.de
Objective:
Comparison of buprenorphine vs. methadone to determine which medication is better for the detoxification of young opioid addicts.
Method:
93 consecutive opioid-dependent patients (ICD-10) from an in-patient detoxification unit for adolescents were investigated, of which 42 chose buprenorphine and 51 chose methadone for detoxification. Both groups did not differ with regard to different sociodemographic and addiction-specific variables such as age, gender, initiation of drug consumption and duration of opioid intake.
Results:
23.5 % of the methadone patients and 38.1 % of the buprenorphine patients finished detoxification successfully, in addition the buprenorphine patients finished detoxification 1.62 days earlier. There was no significant difference concerning these items.
Conclusion:
Buprenorphine seems to be at least as effective as methadone for opioid withdrawal in young addicts.
More Related Videos
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
13:18Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion
Published on: November 22, 2024
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Drug Abuse and Addiction: Pharmacological Phenomena
Pharmaceutical Poisoning: Treatment Strategies
Drug Dependence
Analgesia and Pain Management